Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel D Banister

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
ACS Chemical Neuroscience|August 10, 2017
Pharmacology of Cumyl-Carboxamide Synthetic Cannabinoid New Psychoactive Substances (NPS) CUMYL-BICA, CUMYL-PICA, CUMYL-5F-PICA, CUMYL-5F-PINACA, and Their AnaloguesMitchell Longworth, Samuel D Banister, Rochelle Boyd, et al.
European Journal of Pharmacology|November 23, 2006
Trishomocubanes: novel sigma ligands modulate cocaine-induced behavioural effectsXiang Liu, Samuel D Banister, MacDonald J Christie, et al.
British Journal of Pharmacology|August 15, 2019
In vitro determination of the efficacy of illicit synthetic cannabinoids at CB<sub>1</sub> receptorsShivani Sachdev, Kiran Vemuri, Samuel D Banister, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2010
Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligandsSamuel D Banister, Iman A Moussa, Corinne Beinat, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2012
Exploration of ring size in a series of cyclic vicinal diamines with σ₁ receptor affinityIman A Moussa, Samuel D Banister, Miral Manoli, et al.
RSC Medicinal Chemistry|January 22, 2021
Reversing binding sensitivity to A147T translocator proteinSophie V Vo, Samuel D Banister, Isaac Freelander, et al.
Journal of Cannabis Research|January 4, 2022
Olivetolic acid, a cannabinoid precursor in Cannabis sativa, but not CBGA methyl ester exhibits a modest anticonvulsant effect in a mouse model of Dravet syndromeLyndsey L Anderson, Michael Udoh, Declan Everett-Morgan, et al.
Drug Testing and Analysis|March 26, 2021
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB<sub>1</sub> receptor activation assays-Part II: Structure activity relationship assessment via a β-arrestin recruitment assayKatharina Elisabeth Grafinger, Annelies Cannaert, Adam Ametovski, et al.
Biochemical Pharmacology|February 24, 2020
Signalling profiles of a structurally diverse panel of synthetic cannabinoid receptor agonistsMonica Patel, Jamie J Manning, David B Finlay, et al.
European Journal of Pharmacology|March 20, 2022
In vitro evaluation of the interaction of the cannabis constituents cannabichromene and cannabichromenic acid with ABCG2 and ABCB1 transportersMaia G Etchart, Lyndsey L Anderson, Adam Ametovski, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
ACS Chemical Neuroscience|August 10, 2017
Pharmacology of Cumyl-Carboxamide Synthetic Cannabinoid New Psychoactive Substances (NPS) CUMYL-BICA, CUMYL-PICA, CUMYL-5F-PICA, CUMYL-5F-PINACA, and Their AnaloguesMitchell Longworth, Samuel D Banister, Rochelle Boyd, et al.
European Journal of Pharmacology|November 23, 2006
Trishomocubanes: novel sigma ligands modulate cocaine-induced behavioural effectsXiang Liu, Samuel D Banister, MacDonald J Christie, et al.
British Journal of Pharmacology|August 15, 2019
In vitro determination of the efficacy of illicit synthetic cannabinoids at CB<sub>1</sub> receptorsShivani Sachdev, Kiran Vemuri, Samuel D Banister, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2010
Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligandsSamuel D Banister, Iman A Moussa, Corinne Beinat, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2012
Exploration of ring size in a series of cyclic vicinal diamines with σ₁ receptor affinityIman A Moussa, Samuel D Banister, Miral Manoli, et al.
RSC Medicinal Chemistry|January 22, 2021
Reversing binding sensitivity to A147T translocator proteinSophie V Vo, Samuel D Banister, Isaac Freelander, et al.
Journal of Cannabis Research|January 4, 2022
Olivetolic acid, a cannabinoid precursor in Cannabis sativa, but not CBGA methyl ester exhibits a modest anticonvulsant effect in a mouse model of Dravet syndromeLyndsey L Anderson, Michael Udoh, Declan Everett-Morgan, et al.
Drug Testing and Analysis|March 26, 2021
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB<sub>1</sub> receptor activation assays-Part II: Structure activity relationship assessment via a β-arrestin recruitment assayKatharina Elisabeth Grafinger, Annelies Cannaert, Adam Ametovski, et al.
Biochemical Pharmacology|February 24, 2020
Signalling profiles of a structurally diverse panel of synthetic cannabinoid receptor agonistsMonica Patel, Jamie J Manning, David B Finlay, et al.
European Journal of Pharmacology|March 20, 2022
In vitro evaluation of the interaction of the cannabis constituents cannabichromene and cannabichromenic acid with ABCG2 and ABCB1 transportersMaia G Etchart, Lyndsey L Anderson, Adam Ametovski, et al.
Pageof 9